ptc therapeutics PTC Therapeutics to Acquire Censa Pharma for Mid-Stage Rare Disease Drug By xconomy.com Published On :: Thu, 07 May 2020 07:09:51 +0000 PTC Therapeutics has reached an agreement to acquire Censa Pharmaceuticals and its lead asset, an experimental metabolic disorder therapy that is now being prepared for a pivotal study. The deal, announced after the market close Wednesday, will bring South Plainfield, NJ-based PTC (NASDAQ: PTCT) another compound for its pipeline of rare disease drugs. Wellesley, MA-based […] Full Article Boston blog main Boston top stories National blog main New York New York blog main New York top stories Arkin Bio Ventures BioMarin Pharmaceutical Biotech Censa Therapeutics clinical trials Drug Development FDA Life Sciences PTC Therapeutics rare disease
ptc therapeutics PTC Therapeutics to acquire Censa Pharmaceutical By www.thepharmaletter.com Published On :: Thu, 07 May 2020 14:18:00 +0100 In another strategic M&A deal announced so far this month, PTC Therapeutics has entered into an agreement… Full Article Biotechnology/Censa Pharmaceuticals/Companies mergers and acquisitions/Metabolics/PTC Therapeutics/Rare diseases/sepiapterin/USA
ptc therapeutics PTC Therapeutics nabs 'phase 3 ready' biotech Censa for just $10M upfront plus stock By www.fiercebiotech.com Published On :: Thu, 07 May 2020 11:05:29 +0000 PTC Therapeutics is adding to its rare disease pipeline with a midstage biotech buyout with a low upfront payment tied in with stock and biobucks. Full Article
